Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
TriCo Bancshares
TCBK
$1.84B
| $15.5M | 0.01% |
303,966
+17,216
| +6% | +$898K |
|
1602
Veracyte
VCYT
$3.7B
| $15.5M | 0.01% |
652,236
+11,728
| +2% | +$273K |
|
1603
Acadia Pharmaceuticals
ACAD
$4.43B
| $15.5M | 0.01% |
971,754
+19,080
| +2% | +$298K |
|
1604
iHeartMedia
IHRT
$543M
| $15.5M | 0.01% |
2,523,574
+448,182
| +22% | +$3.45M |
|
1605
Virtu Financial
VIRT
$5.11B
| $15.4M | 0.01% |
756,822
+45,015
| +6% | +$977K |
|
1606
Northern Oil and Gas
NOG
$2.3B
| $15.4M | 0.01% |
500,508
+4,982
| +1% | +$168K |
|
1607
Huron Consulting
HURN
$2.41B
| $15.4M | 0.01% |
212,346
-13,769
| -6% | -$1.01M |
|
|
RPT
1608
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $15.4M | 0.01% |
1,534,294
-45,356
| -3% | -$448K |
|
1609
Tandem Diabetes Care
TNDM
$1.34B
| $15.4M | 0.01% |
342,526
+8,562
| +3% | +$388K |
|
|
PRA
1610
DELISTED
ProAssurance
PRA
| $15.4M | 0.01% |
880,361
-2,106
| -0.2% | -$41.5K |
|
1611
ASML
ASML
$626B
| $15.4M | 0.01% |
28,141
+1,499
| +6% | +$785K |
|
1612
Glaukos
GKOS
$9.83B
| $15.3M | ﹤0.01% |
351,358
+7,104
| +2% | +$350K |
|
1613
BGC Group
BGC
$5.45B
| $15.3M | ﹤0.01% |
4,067,385
+36,203
| +0.9% | +$143K |
|
|
CERE
1614
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $15.3M | ﹤0.01% |
485,344
+17,558
| +4% | +$495K |
|
1615
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$252M
| $15.3M | ﹤0.01% |
383,540
-209,442
| -35% | -$7.99M |
|
1616
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.4B
| $15.3M | ﹤0.01% |
+526,152
| New | +$15.4M |
|
|
TWO
1617
Two Harbors Investment
TWO
$1.27B
| $15.3M | ﹤0.01% |
968,337
-31,838
| -3% | -$478K |
|
1618
AtriCure
ATRC
$1.92B
| $15.3M | ﹤0.01% |
343,781
+8,579
| +3% | +$358K |
|
1619
Scholastic
SCHL
$767M
| $15.2M | ﹤0.01% |
386,128
-9,448
| -2% | -$351K |
|
1620
Acushnet Holdings
GOLF
$5.93B
| $15.2M | ﹤0.01% |
357,995
+7,447
| +2% | +$336K |
|
1621
Amdocs
DOX
$5.92B
| $15.2M | ﹤0.01% |
167,172
-1,849
| -1% | -$157K |
|
1622
Par Pacific Holdings
PARR
$4.31B
| $15.2M | ﹤0.01% |
652,512
-52,922
| -8% | -$1.15M |
|
|
SASR
1623
DELISTED
Sandy Spring Bancorp Inc
SASR
| $15.2M | ﹤0.01% |
430,361
+15,837
| +4% | +$556K |
|
1624
Hertz
HTZ
$500M
| $15.1M | ﹤0.01% |
984,100
-30,358
| -3% | -$511K |
|
|
KNBE
1625
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $15.1M | ﹤0.01% |
608,584
+31,361
| +5% | +$763K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.